SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Shutters who wrote (67)10/16/1997 9:13:00 AM
From: Alan Brezin   of 370
 
Tom,

Nice to have you doing the tech anal on this. I am impressed with the fundementals from what I've learned so far. I have got to get a formal education in tech anal as I have always relied on a traders intuition.

The board of directors and other resources of this company are phenomenal. Execs and fomer execs from BMY, IMNX, REvlon, IBM, MRK,
General Foods, CITI, et al..

The scientific staff is equally impressive and the science looks top notch.

I hear they are getting a hugh cash infusion at a premium to the current stock price but I need to check this out further.

Why can't HIV do it this way. Take a look at TCEL by the way. I have been in that , small position that just got bigger, for many years. That's the way these biotechs are. You have to have patience and a good suspension and seat belts.

Regards,

Alan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext